The Food and Drug Administration has changed the guidelines for the abortion pill in the last month. This will allow women in Texas to take the pill further into the pregnancy and have fewer doctors visits.

The change reduces the dosage of the drug, mifepristone, by 400 milligrams, increasing the window to take the pill by three weeks, and shortening medical visits to two. These new guidelines are considered a victory for abortion rights advocates who have been fighting for doctors to follow the FDA’s guidelines which have become more relaxed.

“I’m against it,” senior Sarah Mitchell said. “They’re making it easier to get ahold of and it should be a harder to get it so the person is able to think about the decision more before taking it.”

According to the New York Times, activists and the American Congress of Obstetricians and Gynecologists are very pleased about the new regulations and believe that they benefit women and their rights. Some Anti-Abortion groups say that the drug led to the death for some women, even though the maker has responded that there was no proof of this.

“It’s better to have access to this drug under certain situation,” sophomore Rachael Hayward said. “But you shouldn’t be able to take it if you just don’t want to be pregnant.”

Both sides are wrapped up in their own opinions and views, which blurs the facts for the public. Even though the FDA approved of the drug and the new routine of taking it, some states have passed laws to restrict the use of it. Some even think that the approval of the label change was planned in a political time-frame. Whether these suspicions are true, the FDA made these new regulations to benefit individual women.

“This is a major shift both in closing the gap between science and legal regulation and in enabling women to exercise their constitutional right to terminate a pregnancy,” law professor Suzanne B. Goldberg told The New York Times.